Reserpine: a tragic victim of myths, marketing, and fashionable prescribing

Clin Pharmacol Ther. 1996 Oct;60(4):368-73. doi: 10.1016/S0009-9236(96)90193-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenergic Antagonists / administration & dosage
  • Adrenergic Antagonists / adverse effects
  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / adverse effects*
  • Antihypertensive Agents / economics
  • Breast Neoplasms / chemically induced
  • Dose-Response Relationship, Drug
  • Humans
  • Hypertension / drug therapy
  • Reserpine / administration & dosage
  • Reserpine / adverse effects*
  • Reserpine / economics

Substances

  • Adrenergic Antagonists
  • Antihypertensive Agents
  • Reserpine